Cardiovascular risk, Cyclosporine, Nephrotoxicity, Renal transplantation, Side-effects, Tacrolimus
dx.doi.org/10.1111/j.1600-6143.2004.00427.x, hdl.handle.net/1765/66584
American Journal of Transplantation
Department of Internal Medicine

Artz, M.A, Boots, J.M.M, Ligtenberg, G, Roodnat, J.I, Christiaans, M.H, Vos, P.F, … Hilbrands, L.B. (2004). Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. American Journal of Transplantation, 4(6), 937–945. doi:10.1111/j.1600-6143.2004.00427.x